Curis Begins Phase I Clinical Study With Vascugel in Coronary Artery Disease
Curis, Inc. (NASDAQ: CRIS) today announced the initiation of a Phase I clinical trial in the U.S. with Vascugel, a cellular transplant […]
You may also like
Hydrogen as Additive of HTK Solution Fortifies Myocardial Preservation in Grafts with Prolonged Cold Ischemia
Hydrogen as additive of HTK solution fortifies HTK's preservation efficacy for cardiac grafts subjected to prolonged cold ischemia by inhibiting cold ischemia-induced up-regulation of oxidative stress, inflammation mediators, and apoptosis.
1 min read
Hemolysis at Different Vacuum Levels During Vacuum-Assisted Venous Drainage: A Prospective Randomized Clinical Trial
The aim of the current study was to compare the hemolytic effects of vacuum-assisted venous drainage (VAVD) at two different vacuum levels with the classical gravity siphon method.
1 min read